These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32387328)

  • 1. Etonogestrel concentrations among contraceptive implant users in Botswana using and not using dolutegravir-based antiretroviral therapy.
    Bishop IJ; Gertz AM; Simon B; Tawe L; Lechiile K; Liu S; Teodoro N; Mussa A; Avalos A; Malima S; Maotwe T; Mokganya L; Westhoff CL; Morroni C
    Contraception; 2020 Sep; 102(3):174-179. PubMed ID: 32387328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral therapy and vaginally administered contraceptive hormones: a three-arm, pharmacokinetic study.
    Scarsi KK; Cramer YS; Rosenkranz SL; Aweeka F; Berzins B; Coombs RW; Coughlin K; Moran LE; Zorrilla CD; Akelo V; Aziz M; Friedman RK; Gingrich D; Swaminathan S; Godfrey C; Cohn SE;
    Lancet HIV; 2019 Sep; 6(9):e601-e612. PubMed ID: 31498109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of double vs single-dose etonogestrel implant to overcome the interaction with efavirenz-based antiretroviral therapy.
    Chappell CA; Lamorde M; Nakalema S; Kyohairwe I; Byakika-Kibwika P; Meyn LA; Pham MM; Scarsi KK
    Am J Obstet Gynecol; 2024 Mar; ():. PubMed ID: 38458408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between etonogestrel-releasing contraceptive implant and 3 antiretroviral regimens.
    Kreitchmann R; Stek A; Best BM; Capparelli E; Wang J; Shapiro D; Chakhtoura N; Mirochnick M; Eke AC;
    Contraception; 2022 Jan; 105():67-74. PubMed ID: 34407424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study.
    Zash R; Jacobson DL; Diseko M; Mayondi G; Mmalane M; Essex M; Gaolethe T; Petlo C; Lockman S; Holmes LB; Makhema J; Shapiro RL
    Lancet Glob Health; 2018 Jul; 6(7):e804-e810. PubMed ID: 29880310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of double-dose levonorgestrel subdermal implant in women taking efavirenz-based antiretroviral therapy: The DoubLNG pharmacokinetic study.
    Cirrincione LR; Nakalema S; Chappell CA; Byakika-Kibwika P; Kyohairwe I; Winchester L; Mackline H; Pham MM; Cohn SE; Siccardi M; Owen A; Fletcher CV; Lamorde M; Scarsi KK
    Contraception; 2023 Jun; 122():109975. PubMed ID: 36787829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of plasma etonogestrel concentrations sampled from the contralateral-to-implant and ipsilateral-to-implant arms of contraceptive implant users.
    Gertz AM; Bishop IJ; Simon B; Lechiile K; Badubi O; Mussa A; Westhoff CL; Morroni C
    Contraception; 2020 Dec; 102(6):403-405. PubMed ID: 32858051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contraceptive implant use duration is not associated with breakthrough pregnancy among women living with HIV and using efavirenz: a retrospective, longitudinal analysis.
    Stalter RM; Amorim G; Mocello AR; Jakait B; Shepherd BE; Musick B; Bernard C; Bukusi EA; Wools-Kaloustian K; Cohen CR; Yiannoutsos CT; Patel RC;
    J Int AIDS Soc; 2022 Sep; 25(9):e26001. PubMed ID: 36073977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with uptake of contraceptives among HIV positive women on dolutegravir based anti-retroviral treatment-a cross sectional survey in urban Uganda.
    Mbabazi L; Nabaggala MS; Kiwanuka S; Kiguli J; Laker E; Kiconco A; Okoboi S; Lamorde M; Castelnuovo B
    BMC Womens Health; 2022 Jun; 22(1):262. PubMed ID: 35761248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gestational diabetes in women living with HIV in Botswana: lower rates with dolutegravir- than with efavirenz-based antiretroviral therapy.
    Mmasa KN; Powis K; Sun S; Makhema J; Mmalane M; Kgole S; Masasa G; Moyo S; Gerschenson M; Mohammed T; Legbedze J; Abrams EJ; Kurland IJ; Geffner ME; Jao J
    HIV Med; 2021 Sep; 22(8):715-722. PubMed ID: 34003565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial.
    Venter WDF; Sokhela S; Simmons B; Moorhouse M; Fairlie L; Mashabane N; Serenata C; Akpomiemie G; Masenya M; Qavi A; Chandiwana N; McCann K; Norris S; Chersich M; Maartens G; Lalla-Edward S; Vos A; Clayden P; Abrams E; Arulappan N; Hill A
    Lancet HIV; 2020 Oct; 7(10):e666-e676. PubMed ID: 33010240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana.
    Zash R; Holmes L; Diseko M; Jacobson DL; Brummel S; Mayondi G; Isaacson A; Davey S; Mabuta J; Mmalane M; Gaolathe T; Essex M; Lockman S; Makhema J; Shapiro RL
    N Engl J Med; 2019 Aug; 381(9):827-840. PubMed ID: 31329379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines.
    Phillips AN; Bansi-Matharu L; Venter F; Havlir D; Pozniak A; Kuritzkes DR; Wensing A; Lundgren JD; Pillay D; Mellors J; Cambiano V; Jahn A; Apollo T; Mugurungi O; Ripin D; Da Silva J; Raizes E; Ford N; Siberry GK; Gupta RK; Barnabas R; Revill P; Cohn J; Calmy A; Bertagnolio S
    Lancet HIV; 2020 Mar; 7(3):e193-e200. PubMed ID: 32035041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of patient genetics on etonogestrel pharmacokinetics when combined with efavirenz or nevirapine ART.
    Neary M; Chappell CA; Scarsi KK; Nakalema S; Matovu J; Achilles SL; Chen BA; Siccardi M; Owen A; Lamorde M
    J Antimicrob Chemother; 2019 Oct; 74(10):3003-3010. PubMed ID: 31299074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding patterns of HIV-infected women using an etonogestrel-releasing contraceptive implant and efavirenz-based or lopinavir/ritonavir-based antiretroviral therapy.
    Ragazini CS; Bahamondes MV; Prandini TR; Brito MB; Amaral E; Bahamondes L; Duarte G; Quintana SM; Ferriani RA; Vieira CS
    Eur J Contracept Reprod Health Care; 2016 Aug; 21(4):285-9. PubMed ID: 27227739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between patient characteristics and serum etonogestrel concentrations in contraceptive implant users.
    Lazorwitz A; Aquilante CL; Sheeder J; Guiahi M; Teal S
    Contraception; 2019 Jul; 100(1):37-41. PubMed ID: 30980827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacokinetic and pharmacogenetic evaluation of contraceptive implants and antiretroviral therapy among women in Kenya and Uganda.
    Patel RC; Stalter RM; Thomas KK; Tamraz B; Blue SW; Erikson DW; Kim CJ; Kelly EJ; Nanda K; Kourtis AP; Lingappa JR; Mugo N; Baeten JM; Scarsi KK;
    AIDS; 2019 Nov; 33(13):1995-2004. PubMed ID: 31306173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant contraceptive implant and efavirenz use in women living with HIV: perspectives on current evidence and policy implications for family planning and HIV treatment guidelines.
    Patel RC; Morroni C; Scarsi KK; Sripipatana T; Kiarie J; Cohen CR
    J Int AIDS Soc; 2017 May; 20(1):21396. PubMed ID: 28530033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized comparison of health-related quality of life outcomes of dolutegravir versus efavirenz-based antiretroviral treatment initiated in the third trimester of pregnancy.
    Ochanda PN; Lamorde M; Kintu K; Wang D; Chen T; Malaba T; Myer L; Waitt C; Reynolds H; Khoo S
    AIDS Res Ther; 2022 Jun; 19(1):24. PubMed ID: 35672853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efavirenz decreases etonogestrel exposure: a pharmacokinetic evaluation of implantable contraception with antiretroviral therapy.
    Chappell CA; Lamorde M; Nakalema S; Chen BA; Mackline H; Riddler SA; Cohn SE; Darin KM; Achilles SL; Scarsi KK
    AIDS; 2017 Sep; 31(14):1965-1972. PubMed ID: 28692531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.